Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Michal Oskar Nowicki, Ph.D.

Title
Institution
Department
Address
Phone

Research
research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
Most Recent  |  List All
  1. R50CA243706 (NOWICKI, MICHAL OSKAR) Sep 17, 2019 - Aug 31, 2024
    NIH
    Innovative approaches for the advancement of glioblastoma therapies
    Role: Principal Investigator

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Koch MS, Zdioruk M, Nowicki MO, Griffith AM, Aguilar-Cordova E, Aguilar LK, Guzik BW, Barone F, Tak PP, Schregel K, Hoetker MS, Lederer JA, Chiocca EA, Tabatabai G, Lawler SE. Perturbing DDR signaling enhances cytotoxic effects of local oncolytic virotherapy and modulates the immune environment in glioma. Mol Ther Oncolytics. 2022 Sep 15; 26:275-288. PMID: 36032633; PMCID: PMC9391522.
    Citations: 1     
  2. Berger G, Knelson EH, Jimenez-Macias JL, Nowicki MO, Han S, Panagioti E, Lizotte PH, Adu-Berchie K, Stafford A, Dimitrakakis N, Zhou L, Chiocca EA, Mooney DJ, Barbie DA, Lawler SE. STING activation promotes robust immune response and NK cell-mediated tumor regression in glioblastoma models. Proc Natl Acad Sci U S A. 2022 07 12; 119(28):e2111003119. PMID: 35787058; PMCID: PMC9282249.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  3. Marloye M, Inam H, Moore CJ, Mertens TR, Ingels A, Koch M, Nowicki MO, Mathieu V, Pritchard JR, Awuah SG, Lawler SE, Meyer F, Dufrasne F, Berger G. Self-assembled ruthenium and osmium nanosystems display a potent anticancer profile by interfering with metabolic activity. Inorg Chem Front. 2022 Jun 07; 9(11):2594-2607. PMID: 36311556; PMCID: PMC9610622.
    Citations:    
  4. Kazmierczak D, Jopek K, Sterzynska K, Nowicki M, Rucinski M, Januchowski R. The Profile of MicroRNA Expression and Potential Role in the Regulation of Drug-Resistant Genes in Cisplatin- and Paclitaxel-Resistant Ovarian Cancer Cell Lines. Int J Mol Sci. 2022 Jan 04; 23(1). PMID: 35008952; PMCID: PMC8745655.
    Citations: 3     Fields:    Translation:HumansCells
  5. Koch MS, Zdioruk M, Nowicki MO, Griffith AM, Aguilar E, Aguilar LK, Guzik BW, Barone F, Tak PP, Tabatabai G, Lederer JA, Chiocca EA, Lawler S. Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models. J Immunother Cancer. 2022 01; 10(1). PMID: 35017150; PMCID: PMC8753448.
    Citations: 2     Fields:    Translation:HumansAnimals
  6. Ketchen SE, Gamboa-Esteves FO, Lawler SE, Nowicki MO, Rohwedder A, Knipp S, Prior S, Short SC, Ladbury JE, Brüning-Richardson A. Drug Resistance in Glioma Cells Induced by a Mesenchymal-Amoeboid Migratory Switch. Biomedicines. 2021 Dec 22; 10(1). PMID: 35052688; PMCID: PMC8773151.
    Citations: 2     
  7. Cieslikowski WA, Antczak A, Nowicki M, Zabel M, Budna-Tukan J. Clinical Relevance of Circulating Tumor Cells in Prostate Cancer Management. Biomedicines. 2021 Sep 08; 9(9). PMID: 34572366; PMCID: PMC8471111.
    Citations: 3     
  8. Kaminska P, Buszka K, Zabel M, Nowicki M, Alix-Panabières C, Budna-Tukan J. Liquid Biopsy in Melanoma: Significance in Diagnostics, Prediction and Treatment Monitoring. Int J Mol Sci. 2021 Sep 08; 22(18). PMID: 34575876.
    Citations: 6     Fields:    Translation:HumansAnimalsCells
  9. Krenzlin H, Zdioruk M, Nowicki MO, Finkelberg T, Keric N, Lemmermann N, Skubal M, Chiocca EA, Cook CH, Lawler SE. Cytomegalovirus infection of glioblastoma cells leads to NF-?B dependent upregulation of the c-MET oncogenic tyrosine kinase. Cancer Lett. 2021 08 10; 513:26-35. PMID: 33989707; PMCID: PMC8209659.
    Citations: 1     Fields:    Translation:HumansAnimalsCells
  10. Wojtowicz K, Sterzynska K, Swierczewska M, Nowicki M, Zabel M, Januchowski R. Piperine Targets Different Drug Resistance Mechanisms in Human Ovarian Cancer Cell Lines Leading to Increased Sensitivity to Cytotoxic Drugs. Int J Mol Sci. 2021 Apr 19; 22(8). PMID: 33921897.
    Citations: 3     Fields:    Translation:HumansCells
  11. Nowacka M, Sterzynska K, Andrzejewska M, Nowicki M, Januchowski R. Drug resistance evaluation in novel 3D in vitro model. Biomed Pharmacother. 2021 Jun; 138:111536. PMID: 34311534.
    Citations: 9     Fields:    Translation:HumansCells
  12. Schregel K, Nowicki MO, Palotai M, Nazari N, Zane R, Sinkus R, Lawler SE, Patz S. Magnetic Resonance Elastography reveals effects of anti-angiogenic glioblastoma treatment on tumor stiffness and captures progression in an orthotopic mouse model. Cancer Imaging. 2020 May 12; 20(1):35. PMID: 32398076.
    Citations: 5     Fields:    Translation:Animals
  13. Lawler SE, Nowicki MO, Ricklefs FL, Chiocca EA. Immune Escape Mediated by Exosomal PD-L1 in Cancer. Adv Biosyst. 2020 12; 4(12):e2000017. PMID: 32383351.
    Citations: 11     Fields:    Translation:HumansAnimalsCells
  14. Dompe C, Janowicz K, Hutchings G, Moncrieff L, Jankowski M, Nawrocki MJ, Józkowiak M, Mozdziak P, Petitte J, Shibli JA, Dyszkiewicz-Konwinska M, Bruska M, Piotrowska-Kempisty H, Kempisty B, Nowicki M. Epigenetic Research in Stem Cell Bioengineering-Anti-Cancer Therapy, Regenerative and Reconstructive Medicine in Human Clinical Trials. Cancers (Basel). 2020 Apr 21; 12(4). PMID: 32326172; PMCID: PMC7226111.
    Citations: 3     
  15. Kazmierczak D, Jopek K, Sterzynska K, Ginter-Matuszewska B, Nowicki M, Rucinski M, Januchowski R. The Significance of MicroRNAs Expression in Regulation of Extracellular Matrix and Other Drug Resistant Genes in Drug Resistant Ovarian Cancer Cell Lines. Int J Mol Sci. 2020 Apr 09; 21(7). PMID: 32283808.
    Citations: 14     Fields:    Translation:HumansCells
  16. Cieslikowski WA, Budna-Tukan J, Swierczewska M, Ida A, Hrab M, Jankowiak A, Mazel M, Nowicki M, Milecki P, Pantel K, Alix-Panabières C, Zabel M, Antczak A. Circulating Tumor Cells as a Marker of Disseminated Disease in Patients with Newly Diagnosed High-Risk Prostate Cancer. Cancers (Basel). 2020 Jan 09; 12(1). PMID: 31936460; PMCID: PMC7017349.
    Citations: 17     
  17. Budna-Tukan J, Swierczewska M, Mazel M, Cieslikowski WA, Ida A, Jankowiak A, Antczak A, Nowicki M, Pantel K, Azria D, Zabel M, Alix-Panabières C. Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration Assays. Cancers (Basel). 2019 Jun 10; 11(6). PMID: 31185699; PMCID: PMC6627099.
    Citations: 11     
  18. Ozegowska K, Brazert M, Ciesiólka S, Nawrocki MJ, Kranc W, Celichowski P, Jankowski M, Bryja A, Jeseta M, Antosik P, Bukowska D, Skowronski MT, Bruska M, Pawelczyk L, Zabel M, Nowicki M, Kempisty B. Genes Involved in the Processes of Cell Proliferation, Migration, Adhesion, and Tissue Development as New Potential Markers of Porcine Granulosa Cellular Processes In Vitro: A Microarray Approach. DNA Cell Biol. 2019 Jun; 38(6):549-560. PMID: 31120353.
    Citations: 11     Fields:    Translation:AnimalsCells
  19. Abdelmoula WM, Regan MS, Lopez BGC, Randall EC, Lawler S, Mladek AC, Nowicki MO, Marin BM, Agar JN, Swanson KR, Kapur T, Sarkaria JN, Wells W, Agar NYR. Automatic 3D Nonlinear Registration of Mass Spectrometry Imaging and Magnetic Resonance Imaging Data. Anal Chem. 2019 05 07; 91(9):6206-6216. PMID: 30932478; PMCID: PMC6691508.
    Citations: 22     Fields:    
  20. Nowicki MO, Hayes JL, Chiocca EA, Lawler SE. Proteomic Analysis Implicates Vimentin in Glioblastoma Cell Migration. Cancers (Basel). 2019 Apr 03; 11(4). PMID: 30987208; PMCID: PMC6521049.
    Citations: 9     
  21. Ogawa D, Ansari K, Nowicki MO, Salinska E, Bronisz A, Godlewski J. MicroRNA-451 Inhibits Migration of Glioblastoma while Making It More Susceptible to Conventional Therapy. Noncoding RNA. 2019 Mar 15; 5(1). PMID: 30875963.
    Citations: 17     
  22. Krenzlin H, Behera P, Lorenz V, Passaro C, Zdioruk M, Nowicki MO, Grauwet K, Zhang H, Skubal M, Ito H, Zane R, Gutknecht M, Griessl MB, Ricklefs F, Ding L, Peled S, Rooj A, James CD, Cobbs CS, Cook CH, Chiocca EA, Lawler SE. Cytomegalovirus promotes murine glioblastoma growth via pericyte recruitment and angiogenesis. J Clin Invest. 2019 03 11; 129(4):1671-1683. PMID: 30855281; PMCID: PMC6436878.
    Citations: 31     Fields:    Translation:HumansAnimalsCells
  23. Bhaskaran V, Nowicki MO, Idriss M, Jimenez MA, Lugli G, Hayes JL, Mahmoud AB, Zane RE, Passaro C, Ligon KL, Haas-Kogan D, Bronisz A, Godlewski J, Lawler SE, Chiocca EA, Peruzzi P. The functional synergism of microRNA clustering provides therapeutically relevant epigenetic interference in glioblastoma. Nat Commun. 2019 01 25; 10(1):442. PMID: 30683859; PMCID: PMC6347618.
    Citations: 51     Fields:    Translation:HumansAnimalsCells
  24. Speranza MC, Passaro C, Ricklefs F, Kasai K, Klein SR, Nakashima H, Kaufmann JK, Ahmed AK, Nowicki MO, Obi P, Bronisz A, Aguilar-Cordova E, Aguilar LK, Guzik BW, Breakefield X, Weissleder R, Freeman GJ, Reardon DA, Wen PY, Chiocca EA, Lawler SE. Preclinical investigation of combined gene-mediated cytotoxic immunotherapy and immune checkpoint blockade in glioblastoma. Neuro Oncol. 2018 01 22; 20(2):225-235. PMID: 29016938; PMCID: PMC5777502.
    Citations: 33     Fields:    Translation:HumansAnimalsCells
  25. Berger G, Grauwet K, Zhang H, Hussey AM, Nowicki MO, Wang DI, Chiocca EA, Lawler SE, Lippard SJ. Anticancer activity of osmium(VI) nitrido complexes in patient-derived glioblastoma initiating cells and in vivo mouse models. Cancer Lett. 2018 03 01; 416:138-148. PMID: 29246647.
    Citations: 6     Fields:    Translation:HumansAnimalsCells
  26. Schregel K, Nazari N, Nowicki MO, Palotai M, Lawler SE, Sinkus R, Barbone PE, Patz S. Characterization of glioblastoma in an orthotopic mouse model with magnetic resonance elastography. NMR Biomed. 2018 10; 31(10):e3840. PMID: 29193449; PMCID: PMC6538416.
    Citations: 12     Fields:    Translation:AnimalsCells
  27. Budna J, Bryja A, Celichowski P, Kahan R, Kranc W, Ciesiólka S, Rybska M, Borys S, Jeseta M, Bukowska D, Antosik P, Brüssow KP, Bruska M, Nowicki M, Zabel M, Kempisty B. Genes of cellular components of morphogenesis in porcine oocytes before and after IVM. Reproduction. 2017 10; 154(4):535-545. PMID: 28733345.
    Citations: 9     Fields:    Translation:AnimalsCells
  28. Zhu Y, Bassoff N, Reinshagen C, Bhere D, Nowicki MO, Lawler SE, Roux J, Shah K. Bi-specific molecule against EGFR and death receptors simultaneously targets proliferation and death pathways in tumors. Sci Rep. 2017 06 01; 7(1):2602. PMID: 28572590.
    Citations: 15     Fields:    Translation:HumansCells
  29. Speranza MC, Nowicki MO, Behera P, Cho CF, Chiocca EA, Lawler SE. BKM-120 (Buparlisib): A Phosphatidyl-Inositol-3 Kinase Inhibitor with Anti-Invasive Properties in Glioblastoma. Sci Rep. 2016 Feb 05; 6:20189. PMID: 26846842.
    Citations: 23     Fields:    Translation:HumansAnimalsCells
  30. Wojtowicz K, Januchowski R, Nowicki M, Zabel M. Inhibition of protein glycosylation reverses the MDR phenotype of cancer cell lines. Biomed Pharmacother. 2015 Aug; 74:49-56. PMID: 26349962.
    Citations: 18     Fields:    Translation:HumansCells
  31. Januchowski R, Zawierucha P, Rucinski M, Andrzejewska M, Wojtowicz K, Nowicki M, Zabel M. Drug transporter expression profiling in chemoresistant variants of the A2780 ovarian cancer cell line. Biomed Pharmacother. 2014 May; 68(4):447-53. PMID: 24814220.
    Citations: 24     Fields:    Translation:HumansCells
  32. Januchowski R, Zawierucha P, Rucinski M, Nowicki M, Zabel M. Extracellular matrix proteins expression profiling in chemoresistant variants of the A2780 ovarian cancer cell line. Biomed Res Int. 2014; 2014:365867. PMID: 24804215.
    Citations: 44     Fields:    Translation:HumansCells
  33. Yan F, Alinari L, Lustberg ME, Martin LK, Cordero-Nieves HM, Banasavadi-Siddegowda Y, Virk S, Barnholtz-Sloan J, Bell EH, Wojton J, Jacob NK, Chakravarti A, Nowicki MO, Wu X, Lapalombella R, Datta J, Yu B, Gordon K, Haseley A, Patton JT, Smith PL, Ryu J, Zhang X, Mo X, Marcucci G, Nuovo G, Kwon CH, Byrd JC, Chiocca EA, Li C, Sif S, Jacob S, Lawler S, Kaur B, Baiocchi RA. Genetic validation of the protein arginine methyltransferase PRMT5 as a candidate therapeutic target in glioblastoma. Cancer Res. 2014 Mar 15; 74(6):1752-65. PMID: 24453002.
    Citations: 63     Fields:    Translation:HumansAnimalsCells
  34. Szymanski D, Durczynski A, Nowicki M, Strzelczyk J. Gastrojejunostomy in patients with unresectable pancreatic head cancer - the use of Roux loop significantly shortens the hospital length of stay. World J Gastroenterol. 2013 Dec 07; 19(45):8321-5. PMID: 24363523.
    Citations: 2     Fields:    Translation:Humans
  35. Bronisz A, Wang Y, Nowicki MO, Peruzzi P, Ansari K, Ogawa D, Balaj L, De Rienzo G, Mineo M, Nakano I, Ostrowski MC, Hochberg F, Weissleder R, Lawler SE, Chiocca EA, Godlewski J. Extracellular vesicles modulate the glioblastoma microenvironment via a tumor suppression signaling network directed by miR-1. Cancer Res. 2014 Feb 01; 74(3):738-750. PMID: 24310399.
    Citations: 124     Fields:    Translation:HumansAnimalsCells
  36. Peruzzi P, Bronisz A, Nowicki MO, Wang Y, Ogawa D, Price R, Nakano I, Kwon CH, Hayes J, Lawler SE, Ostrowski MC, Chiocca EA, Godlewski J. MicroRNA-128 coordinately targets Polycomb Repressor Complexes in glioma stem cells. Neuro Oncol. 2013 Sep; 15(9):1212-24. PMID: 23733246; PMCID: PMC3748913.
    Citations: 71     Fields:    Translation:HumansAnimalsCells
  37. Price RL, Song J, Bingmer K, Kim TH, Yi JY, Nowicki MO, Mo X, Hollon T, Murnan E, Alvarez-Breckenridge C, Fernandez S, Kaur B, Rivera A, Oglesbee M, Cook C, Chiocca EA, Kwon CH. Cytomegalovirus contributes to glioblastoma in the context of tumor suppressor mutations. Cancer Res. 2013 Jun 01; 73(11):3441-50. PMID: 23729642.
    Citations: 30     Fields:    Translation:HumansAnimalsCells
  38. Alvarez-Breckenridge CA, Yu J, Price R, Wei M, Wang Y, Nowicki MO, Ha YP, Bergin S, Hwang C, Fernandez SA, Kaur B, Caligiuri MA, Chiocca EA. The histone deacetylase inhibitor valproic acid lessens NK cell action against oncolytic virus-infected glioblastoma cells by inhibition of STAT5/T-BET signaling and generation of gamma interferon. J Virol. 2012 Apr; 86(8):4566-77. PMID: 22318143.
    Citations: 55     Fields:    Translation:HumansAnimalsCells
  39. Agudelo-Garcia PA, De Jesus JK, Williams SP, Nowicki MO, Chiocca EA, Liyanarachchi S, Li PK, Lannutti JJ, Johnson JK, Lawler SE, Viapiano MS. Glioma cell migration on three-dimensional nanofiber scaffolds is regulated by substrate topography and abolished by inhibition of STAT3 signaling. Neoplasia. 2011 Sep; 13(9):831-40. PMID: 21969816.
    Citations: 44     Fields:    Translation:HumansAnimalsCells
  40. Williams SP, Nowicki MO, Liu F, Press R, Godlewski J, Abdel-Rasoul M, Kaur B, Fernandez SA, Chiocca EA, Lawler SE. Indirubins decrease glioma invasion by blocking migratory phenotypes in both the tumor and stromal endothelial cell compartments. Cancer Res. 2011 Aug 15; 71(16):5374-80. PMID: 21697283.
    Citations: 39     Fields:    Translation:HumansAnimalsCells
  41. Slupianek A, Poplawski T, Jozwiakowski SK, Cramer K, Pytel D, Stoczynska E, Nowicki MO, Blasiak J, Skorski T. BCR/ABL stimulates WRN to promote survival and genomic instability. Cancer Res. 2011 Feb 01; 71(3):842-51. PMID: 21123451.
    Citations: 28     Fields:    Translation:HumansAnimalsCells
  42. Estrada-Bernal A, Lawler SE, Nowicki MO, Ray Chaudhury A, Van Brocklyn JR. The role of sphingosine kinase-1 in EGFRvIII-regulated growth and survival of glioblastoma cells. J Neurooncol. 2011 May; 102(3):353-66. PMID: 20938717.
    Citations: 23     Fields:    Translation:HumansAnimalsCells
  43. Godlewski J, Bronisz A, Nowicki MO, Chiocca EA, Lawler S. microRNA-451: A conditional switch controlling glioma cell proliferation and migration. Cell Cycle. 2010 Jul 15; 9(14):2742-8. PMID: 20647762.
    Citations: 91     Fields:    Translation:HumansCells
  44. Jodynis-Liebert J, Nowicki M, Murias M, Adamska T, Ewertowska M, Kujawska M, Piotrowska H, Konwerska A, Ostalska-Nowicka D, Pernak J. Cytotoxicity, acute and subchronic toxicity of ionic liquid, didecyldimethylammonium saccharinate, in rats. Regul Toxicol Pharmacol. 2010 Jul-Aug; 57(2-3):266-73. PMID: 20347908.
    Citations: 8     Fields:    Translation:HumansAnimalsCells
  45. Godlewski J, Nowicki MO, Bronisz A, Nuovo G, Palatini J, De Lay M, Van Brocklyn J, Ostrowski MC, Chiocca EA, Lawler SE. MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells. Mol Cell. 2010 Mar 12; 37(5):620-32. PMID: 20227367; PMCID: PMC3125113.
    Citations: 215     Fields:    Translation:HumansAnimalsCells
  46. Kim Y, Lawler S, Nowicki MO, Chiocca EA, Friedman A. A mathematical model for pattern formation of glioma cells outside the tumor spheroid core. J Theor Biol. 2009 Oct 07; 260(3):359-71. PMID: 19596356.
    Citations: 38     Fields:    Translation:HumansCells
  47. Suzuki M, Kasai K, Ohtsuki A, Godlewski J, Nowicki MO, Chiocca EA, Saeki Y. ICP0 inhibits the decrease of HSV amplicon-mediated transgene expression. Mol Ther. 2009 Apr; 17(4):707-15. PMID: 19223864.
    Citations: 5     Fields:    Translation:AnimalsCells
  48. Godlewski J, Nowicki MO, Bronisz A, Williams S, Otsuki A, Nuovo G, Raychaudhury A, Newton HB, Chiocca EA, Lawler S. Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res. 2008 Nov 15; 68(22):9125-30. PMID: 19010882.
    Citations: 362     Fields:    Translation:HumansAnimalsCells
  49. Nowicki MO, Dmitrieva N, Stein AM, Cutter JL, Godlewski J, Saeki Y, Nita M, Berens ME, Sander LM, Newton HB, Chiocca EA, Lawler S. Lithium inhibits invasion of glioma cells; possible involvement of glycogen synthase kinase-3. Neuro Oncol. 2008 Oct; 10(5):690-9. PMID: 18715951.
    Citations: 64     Fields:    Translation:HumansAnimalsCells
  50. Kurozumi K, Hardcastle J, Thakur R, Shroll J, Nowicki M, Otsuki A, Chiocca EA, Kaur B. Oncolytic HSV-1 infection of tumors induces angiogenesis and upregulates CYR61. Mol Ther. 2008 Aug; 16(8):1382-91. PMID: 18545226.
    Citations: 43     Fields:    Translation:HumansAnimalsCells
  51. Stein AM, Nowicki MO, Demuth T, Berens ME, Lawler SE, Chiocca EA, Sander LM. Estimating the cell density and invasive radius of three-dimensional glioblastoma tumor spheroids grown in vitro. Appl Opt. 2007 Aug 01; 46(22):5110-8. PMID: 17676121.
    Citations: 2     Fields:    Translation:HumansCells
  52. Koptyra M, Falinski R, Nowicki MO, Stoklosa T, Majsterek I, Nieborowska-Skorska M, Blasiak J, Skorski T. BCR/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance. Blood. 2006 Jul 01; 108(1):319-27. PMID: 16527898; PMCID: PMC1895841.
    Citations: 124     Fields:    Translation:AnimalsCells
  53. Trojanek J, Croul S, Ho T, Wang JY, Darbinyan A, Nowicki M, Del Valle L, Skorski T, Khalili K, Reiss K. T-antigen of the human polyomavirus JC attenuates faithful DNA repair by forcing nuclear interaction between IRS-1 and Rad51. J Cell Physiol. 2006 Jan; 206(1):35-46. PMID: 15965906.
    Citations: 37     Fields:    Translation:HumansAnimalsCells
  54. Slupianek A, Nowicki MO, Koptyra M, Skorski T. BCR/ABL modifies the kinetics and fidelity of DNA double-strand breaks repair in hematopoietic cells. DNA Repair (Amst). 2006 Feb 03; 5(2):243-50. PMID: 16297667; PMCID: PMC2856314.
    Citations: 32     Fields:    Translation:AnimalsCells
  55. Slupianek A, Gurdek E, Koptyra M, Nowicki MO, Siddiqui KM, Groden J, Skorski T. BLM helicase is activated in BCR/ABL leukemia cells to modulate responses to cisplatin. Oncogene. 2005 Jun 02; 24(24):3914-22. PMID: 15750625.
    Citations: 12     Fields:    Translation:HumansAnimalsCells
  56. Stoklosa T, Slupianek A, Datta M, Nieborowska-Skorska M, Nowicki MO, Koptyra M, Skorski T. BCR/ABL recruits p53 tumor suppressor protein to induce drug resistance. Cell Cycle. 2004 Nov; 3(11):1463-72. PMID: 15492510.
    Citations: 6     Fields:    Translation:HumansAnimalsCells
  57. Nowicki MO, Falinski R, Koptyra M, Slupianek A, Stoklosa T, Gloc E, Nieborowska-Skorska M, Blasiak J, Skorski T. BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species-dependent DNA double-strand breaks. Blood. 2004 Dec 01; 104(12):3746-53. PMID: 15304390.
    Citations: 92     Fields:    Translation:AnimalsCells
  58. Trojanek J, Ho T, Del Valle L, Nowicki M, Wang JY, Lassak A, Peruzzi F, Khalili K, Skorski T, Reiss K. Role of the insulin-like growth factor I/insulin receptor substrate 1 axis in Rad51 trafficking and DNA repair by homologous recombination. Mol Cell Biol. 2003 Nov; 23(21):7510-24. PMID: 14559999.
    Citations: 48     Fields:    Translation:HumansAnimalsCells
  59. Nowicki MO, Pawlowski P, Fischer T, Hess G, Pawlowski T, Skorski T. Chronic myelogenous leukemia molecular signature. Oncogene. 2003 Jun 19; 22(25):3952-63. PMID: 12813469.
    Citations: 37     Fields:    Translation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Nowicki's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (320)
Explore
_
Co-Authors (27)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2023 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.